D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CALL
Cognex
CGNX
$10.3B
| $496K | ﹤0.01% |
9,000
| – | – |
|
2877
PUT
Quest Diagnostics
DGX
$25.1B
| $496K | ﹤0.01% |
+5,300
| New | +$563K |
|
|
BKCC
2878
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $496K | ﹤0.01% |
+66,149
| New | +$488K |
|
|
DO
2879
CALL
DELISTED
Diamond Offshore Drilling
DO
| $496K | ﹤0.01% |
34,200
-8,700
| -20% | -$105K |
|
|
LKSD
2880
CALL
DELISTED
LSC Communications, Inc.
LKSD
| $495K | ﹤0.01% |
30,000
| – | – |
|
2881
PUT
Mastercard
MA
$477B
| $494K | ﹤0.01% |
+3,500
| New | +$463K |
|
2882
Peoples Bancorp
PEBO
$1.45B
| $492K | ﹤0.01% |
14,662
-275
| -2% | -$8.72K |
|
|
RDC
2883
DELISTED
Rowan Companies Plc
RDC
| $492K | ﹤0.01% |
38,264
-540,115
| -93% | -$5.79M |
|
2884
Enova International
ENVA
$5.91B
| $490K | ﹤0.01% |
36,427
-16,217
| -31% | -$220K |
|
2885
PUT
DexCom
DXCM
$27.6B
| $489K | ﹤0.01% |
+40,000
| New | +$707K |
|
2886
NOV
NOV
$7.45B
| $489K | ﹤0.01% |
13,690
-2,787
| -17% | -$91K |
|
2887
Weis Markets
WMK
$1.82B
| $489K | ﹤0.01% |
+11,249
| New | +$511K |
|
|
HTB
2888
HomeTrust Bancshares
HTB
$818M
| $489K | ﹤0.01% |
19,066
+2,069
| +12% | +$49.4K |
|
|
PAY
2889
PUT
DELISTED
Verifone Systems Inc
PAY
| $489K | ﹤0.01% |
24,100
-112,000
| -82% | -$2.19M |
|
|
HAPN
2890
CALL
Happen Inc
HAPN
$2.08B
| $487K | ﹤0.01% |
16,000
| – | – |
|
2891
Deluxe
DLX
$1.19B
| $484K | ﹤0.01% |
6,635
-35,673
| -84% | -$2.49M |
|
|
SRCI
2892
CALL
DELISTED
SRC Energy Inc
SRCI
| $484K | ﹤0.01% |
+50,000
| New | +$395K |
|
2893
Helen of Troy
HELE
$663M
| $483K | ﹤0.01% |
4,982
-6,995
| -58% | -$673K |
|
|
AUD
2894
DELISTED
Audacy, Inc.
AUD
| $482K | ﹤0.01% |
42,074
+26,349
| +168% | +$269K |
|
|
PX
2895
DELISTED
Praxair Inc
PX
| $482K | ﹤0.01% |
3,451
+325
| +10% | +$43.3K |
|
2896
CALL
Brighthouse Financial
BHF
$3.63B
| $480K | ﹤0.01% |
+7,893
| New | +$450K |
|
2897
CEVA Inc
CEVA
$1.01B
| $480K | ﹤0.01% |
11,214
+2,691
| +32% | +$116K |
|
2898
CALL
Capri Holdings
CPRI
$1.77B
| $479K | ﹤0.01% |
10,000
| – | – |
|
|
DMC
2899
Del Monte Corp
DMC
$1.35B
| $479K | ﹤0.01% |
10,545
-13,318
| -56% | -$647K |
|
|
ADMS
2900
DELISTED
Adamas Pharmaceuticals
ADMS
| $477K | ﹤0.01% |
+22,526
| New | +$413K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.